Response to Comment on Francés et al. Hepatic Cyclooxygenase-2 Expression Protects Against Diet-Induced Steatosis, Obesity, and Insulin Resistance. Diabetes 2015;64:1522–1531 | Zendy

Ángela M. Valverde | Zendy; Paloma MartínSanz | Zendy

Open Access

Response to Comment on Francés et al. Hepatic Cyclooxygenase-2 Expression Protects Against Diet-Induced Steatosis, Obesity, and Insulin Resistance. Diabetes 2015;64:1522–1531

Author(s) -

Ángela M. Valverde,

Paloma MartínSanz

Publication year - 2015

Publication title -

diabetes

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.219

H-Index - 330

eISSN - 1939-327X

pISSN - 0012-1797

DOI - 10.2337/dbi15-0023

Subject(s) - celecoxib , steatosis , insulin resistance , medicine , endocrinology , overweight , cyclooxygenase , basal (medicine) , placebo , insulin sensitivity , obesity , diabetes mellitus , insulin , biology , enzyme , biochemistry , alternative medicine , pathology

In their comment, González-Ortiz et al. cited their study that reported that in a randomized, doubleblind, placebo-controlled clinical trial of 12 overweight or obese male volunteers, of whom 6 received celecoxib for 4 weeks, the insulin sensitivity after celecoxib treatment was significantly higher compared with the basal estimation.Peer Reviewe

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research